Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era
This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.
Authors
- Patrick Sweigert (ORCID: https://orcid.org/0000-0001-9630-6482)
- Grace F. Chao (ORCID: https://orcid.org/0000-0003-3133-9827)
- Stefanie Rohde (ORCID: https://orcid.org/0000-0003-2689-6848)
- Mohamed I. Elsaid
Institutions
- The Ohio State University Wexner Medical Center (US)
- Wake Forest University (US)
Publication Details
- Journal
- JAMA Surgery
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1001/jamasurg.2026.0049
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00